0001209191-15-043311.txt : 20150515
0001209191-15-043311.hdr.sgml : 20150515
20150515161636
ACCESSION NUMBER: 0001209191-15-043311
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150513
FILED AS OF DATE: 20150515
DATE AS OF CHANGE: 20150515
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15869665
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-05-13
4
M
0
1300
17.16
A
387584
D
Common Stock
2015-05-13
4
M
0
10400
35.64
A
397984
D
Common Stock
2015-05-13
4
S
0
3499
125.71
D
394485
D
Common Stock
2015-05-13
4
S
0
1100
126.45
D
393385
D
Common Stock
2015-05-13
4
S
0
1500
127.69
D
391885
D
Common Stock
2015-05-13
4
S
0
5001
128.63
D
386884
D
Common Stock
2015-05-13
4
S
0
600
129.63
D
386284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
17.16
2015-05-13
4
M
0
1300
0.00
D
2015-07-19
Common Stock
1300
12200
D
Stock Option (right to buy)
35.64
2015-05-13
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
385600
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $125.71 (range $125.04 to $126.03).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $126.45 (range $126.05 to $127.01).
Open market sales reported on this line occurred at a weighted average price of $127.69 (range $127.12 to $128.06).
Open market sales reported on this line occurred at a weighted average price of $128.63 (range $128.18 to $129.13).
Open market sales reported on this line occurred at a weighted average price of $129.63 (range $129.36 to $129.97).
Common stock held in grantor retained annuity trusts.
Fully vested.
Omar White, Attorney-In-Fact
2015-05-15